What does this research mean for the field?

Optogenetic excitation of PVN OXT increases systolic blood pressure (SBP) and elicits bradycardia, which is abolished by a V1aR antagonist. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to explore how oxytocin released in the brain influences blood pressure regulation via vasopressin neural pathways.

February 2, 2026

Oxytocin and Vasopressin Cross Talk Within the Brain Increases Blood Pressure

Key Result

Optogenetic excitation of PVN OXT increased systolic blood pressure (SBP) and elicited bradycardia, which was abolished by a V1aR antagonist.

Key Points

This research aims to explore how oxytocin released in the brain influences blood pressure regulation via vasopressin neural pathways.
Experiments carried out ex vivo and in vivo using mice with genetically altered neuron expression for oxytocin and channelrhodopsin.
Optogenetic techniques were implemented to stimulate oxytocin neurons and measure effects on blood pressure and heart rate.
Immunolabeling and action potential recording confirmed oxytocin neuron functionality.
Optogenetic stimulation of oxytocin neurons in the hypothalamus increased systolic blood pressure by over 90%.
The bradycardia response was abolished by ganglionic blockade, indicating a neuroendocrine mechanism for blood pressure increase.
Firing of oxytocin neurons promoted calcium flux and the release of oxytocin, influencing vasopressin neuron activity.

Structured PICO

Population

Mice with expression of ChR2 and EYFP directed to cells synthesizing OXT (OXT-ChR2) and Chinese hamster ovary cells expressing OXT or V1aR receptors

Intervention

Optogenetic excitation of PVN OXT neurons

Comparator

Control OXT-Cre mice without ChR2

Outcome

Systolic blood pressure (SBP) and heart ratesurrogate

Firing of PVN OXT neurons promotes paracrine release of OXT, activating V1aR on vasopressin-synthesizing neurons to drive vasopressin secretion and elevate systolic blood pressure.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

BACKGROUND: The paraventricular nucleus of the hypothalamus (PVN) orchestrates neuroendocrine and autonomic output to maintain systolic blood pressure (SBP). Emerging evidence suggests that the PVN utilizes paracrine signals to modulate neighboring neurons. Here, we test the hypothesis that OXT (oxytocin) synthesizing neurons of the paraventricular nucleus (PVN OXT ) release paracrine signals that regulate SBP via modulation of vasopressin-synthesizing neurons of the paraventricular nucleus. METHODS: To test the hypothesis, experiments were conducted ex vivo and in vivo in mice with the expression of ChR2 (channelrhodopsin-2) and EYFP (enhanced yellow fluorescent protein) directed to cells synthesizing OXT. RESULTS: We found >90% of EYFP-neurons were immunolabeled for OXT, and blue light elicited action potentials in these neurons. This confirmed directed/functional expression of ChR2-EYFP within PVN OXT . In vivo optogenetic excitation of PVN OXT increased SBP and elicited bradycardia in OXT-ChR2 (mice expressing EYFP-ChR2 directed to the OXT gene) compared with control OXT-Cre (mice expressing Cre-recombinase directed to the OXT gene) mice without ChR2. Ganglionic blockade had no effect on the increased SBP, but it abolished the bradycardia. These results suggest that exciting PVN OXT likely recruits a neuroendocrine signal to promote vasoconstriction, thus eliciting the baroreflex to induce bradycardia. Consistent with this interpretation, optogenetic excitation of PVN OXT increased circulating OXT; however, the elevated SBP persisted after administration of the OXT receptor antagonist. Intriguingly, in vitro optogenetic excitation of PVN OXT evoked Ca 2+ flux in Chinese hamster ovary cells expressing OXT receptors or vasopressin receptors (V1aR vasopressin receptor 1a), suggesting that firing of PVN OXT promotes local release of OXT. Optogenetic excitation of PVN OXT augmented firing of vasopressin-synthesizing neurons of the paraventricular nucleus and tended to increase circulating AVP (arginine vasopressin). Remarkably, systemic or central administration of a V1aR antagonist abolished the increased SBP and bradycardia after excitation of PVN OXT . CONCLUSIONS: Collectively, our results reveal that firing of PVN OXT promotes paracrine release of OXT, which via activation of V1aR(s) expressed on vasopressin-synthesizing neurons of the paraventricular nucleus, drives vasopressin secretion that elevates SBP.